Fundz

Mytide Therapeutics reported raising $7.07 Million in an initial SEC Form D filing, from an offering of $2.5 Million

PRIVATEJan 06, 2023

Amount Raised

$7.07 Million

$7.07 Million sold, per SEC Form D (first sale Dec 23, 2022)

Round Type

Venture

BostonBiotechnology

Quick answer

Mytide Therapeutics, Inc. raised $7.07 Million in a funding round, dated December 23, 2022. Mytide Therapeutics, Inc. is based in Boston, Massachusetts, United States.

How much did Mytide Therapeutics, Inc. raise?
Mytide Therapeutics, Inc. raised $7.07 Million in a funding round on December 23, 2022.
What does Mytide Therapeutics, Inc. do?
mytide is a groundbreaking technology startup focused on accelerating peptide therapeutics R&D.
Where is Mytide Therapeutics, Inc. based and how big is it?
Mytide Therapeutics, Inc. is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Mytide Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Sensible Biotechnologies raised $1.8M (Pre-Seed) on February 6, 2023.
  • Deka Biosciences, Inc. raised $30M on February 6, 2023.
  • Sabai Global raised an undisclosed amount on February 6, 2023.
  • 76Bio, Inc. raised $12M on February 6, 2023.
  • PaxMedica raised $3.2M (Seed) on February 3, 2023.
  • Incepto raised $3M (Seed) on February 3, 2023.

Who to call at Mytide Therapeutics, Inc., and when

A new round usually means Mytide Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mytide Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mytide Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mytide Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mytide Therapeutics, Inc.

Location

451 D STREET SUITE 707

Boston, Massachusetts, United States

About

mytide is a groundbreaking technology startup focused on accelerating peptide therapeutics R&D. We are a multi-disciplinary team of engineers, biochemists, and computer scientists who have created the first company to take a technologically advanced approach to solving long-standing challenges in both peptide synthesis and purification. mytide's fully automated peptide manufacturing technology, coupled with predictive analytics and machine learning, is challenging decades-old paradigms to enable cost-efficient research and development, therapeutic manufacturing and therapeutic discovery. Our aim is to accelerate the discovery and development of life-saving peptide therapeutics for serious conditions ranging from metabolic conditions to cancer to inflammatory disorders to infectious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mytide Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mytide Therapeutics, Inc.'s next move

See what Strategic adds

Mytide Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.